Moderna and Pfizer, pharmaceutical companies, have released their findings of recent clinical trials of their respective Covid-19 vaccinations. Both of these trials produced overwhelmingly positive results.

Pfizer released recently that their Covid-19 vaccination has an efficacy of around 90%. They have since begun a pilot delivery trial in four states to address some of the distribution challenges posed by their vaccine requirements. The Pfizer vaccine has to be stored at -94 degrees Fahrenheit. Some concerns have been raised about this incredibly low temperature. Many clinics around the United States do not have the capabilities of storing a vaccine at these temperatures, especially in rural areas.

Moderna has also released news of their Covid-19 drug trials, stating that their vaccine has an efficacy of 94.5%. According to NPR, Moderna conducted a test with 30,000 volunteers, giving half two doses of the vaccine and the other half of the participants two doses of the placebo on the same schedule. Out of the 95 cases of Covid-19 among the participants, only five were from the vaccinated group. Moderna has stated that their vaccine needs to be stored at 25 degrees Fahrenheit, a temperature that a home freezer can easily reach, making this vaccine more readily available to clinics in any part of the country.

While these vaccine trials are still ongoing, and more research needs to be conducted to vaccinate the public, these trials are hopeful.

C & A Scientific is a dedicated leader in improving the health and minds of people worldwide. We supply over 700 award-winning medical and STEM-inspired products to distributors and retailers looking for sensational customer service. Learn more about us and our story here.

Medical Advancements

Contact supplier

Stay in the loop!